Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Sana Biotechnology Filed U.S. Patent Application #20240010988: Genetically Modified Primary Cells For Allogeneic Cell Therapy

Author: Charles Gross | January 11, 2024 12:39pm

https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240010988

Posted In: SANA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist